Day One Biopharmaceuticals, Inc.DAWNNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-86.32M
Near historical average
Average (5y)
$-88.79M
Historical baseline
Range
High:$-2000.00
Low:$-188.53M
CAGR
+745.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-86.32M | +54.2% |
| 2023 | $-188.53M | -33.1% |
| 2022 | $-141.65M | -95.2% |
| 2021 | $-72.56M | -66.2% |
| 2020 | $-43.66M | -2182800.0% |
| 2019 | $-2000.00 | - |